There were 255 press releases posted in the last 24 hours and 404,199 in the last 365 days.

Paediatric investigation plans: questions and answers

EMA is running a pilot for a 'stepwise PIP' agreement which would introduce a partial development programme supporting the authorisation of innovative medicines for children.

This programme would be conditional on the development of a full PIP once sufficient evidence becomes available. It would rely on predefined steps agreed with the EMA's Paediatric Committee (PDCO), such as applicants being able to hold discussions with the PDCO once they obtain more data.

Guidance on the stepwise PIP pilot is available below:

English (EN) (236.52 KB - PDF)

First published:

View

A stepwise PIP would apply to cases where there is a lack of crucial information needed to decide on certain parts of the paediatric investigation plan, such as whether a clinical study for a whole age group is necessary.

EMA launched this pilot in February 2023. It is due for review upon the adoption of eight initial opinions on stepwise PIPs.

Legal Disclaimer:

EIN Presswire provides this news content "as is" without warranty of any kind. We do not accept any responsibility or liability for the accuracy, content, images, videos, licenses, completeness, legality, or reliability of the information contained in this article. If you have any complaints or copyright issues related to this article, kindly contact the author above.